Alexander-Miller MA - Search Results

1

Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.

Stirling ER, Terabe M, Wilson AS, Kooshki M, Yamaleyeva LM, Alexander-Miller MA, Zhang W, Miller LD, Triozzi PL, Soto-Pantoja DR. Stirling ER, et al. Among authors: alexander miller ma. J Immunother Cancer. 2022 Nov;10(11):e004712. doi: 10.1136/jitc-2022-004712. J Immunother Cancer. 2022. PMID: 36418073 Free PMC article.

2

Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.

Alexander-Miller MA, Parker KC, Tsukui T, Pendleton CD, Coligan JE, Berzofsky JA. Alexander-Miller MA, et al. Int Immunol. 1996 May;8(5):641-9. doi: 10.1093/intimm/8.5.641. Int Immunol. 1996. PMID: 8671651

3

Definition of TCR recognition sites on Ld-tum- complexes.

Alexander-Miller M, Robinson RA, Smith JD, Gillanders WE, Harrison LG, Hansen TH, Connolly JM, Lee DR. Alexander-Miller M, et al. Int Immunol. 1994 Nov;6(11):1699-707. doi: 10.1093/intimm/6.11.1699. Int Immunol. 1994. PMID: 7865463

4

Cytotoxic T lymphocyte (CTL) adherence assay (CAA): a non-radioactive assay for murine CTL recognition of peptide-MHC class I complexes.

Leggatt GR, Alexander-Miller MA, Kumar A, Hoffman SL, Berzofsky JA. Leggatt GR, et al. J Immunol Methods. 1997 Feb 14;201(1):1-10. doi: 10.1016/s0022-1759(96)00203-7. J Immunol Methods. 1997. PMID: 9053406

5

Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma.

Kurokohchi K, Carrington M, Mann DL, Simonis TB, Alexander-Miller MA, Feinstone SM, Akatsuka T, Berzofsky JA. Kurokohchi K, et al. Hepatology. 1996 May;23(5):1181-8. doi: 10.1002/hep.510230537. Hepatology. 1996. PMID: 8621152

6

Specific prolongation of allograft survival by a T-cell-receptor-derived peptide.

Goss JA, Alexander-Miller MA, Gorka J, Flye MW, Connolly JM, Hansen TH. Goss JA, et al. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9872-6. doi: 10.1073/pnas.90.21.9872. Proc Natl Acad Sci U S A. 1993. PMID: 8234328 Free PMC article.

7

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

Derby M, Alexander-Miller M, Tse R, Berzofsky J. Derby M, et al. J Immunol. 2001 Feb 1;166(3):1690-7. doi: 10.4049/jimmunol.166.3.1690. J Immunol. 2001. PMID: 11160212

8

Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.

Solheim JC, Alexander-Miller MA, Martinko JM, Connolly JM. Solheim JC, et al. J Immunol. 1993 Feb 1;150(3):800-11. J Immunol. 1993. PMID: 8380825

9

Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.

Alexander-Miller MA, Burke K, Koszinowski UH, Hansen TH, Connolly JM. Alexander-Miller MA, et al. J Immunol. 1993 Jul 1;151(1):1-10. J Immunol. 1993. PMID: 8392095

10

Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq.

Song Q, Hawkins GA, Wudel L, Chou PC, Forbes E, Pullikuth AK, Liu L, Jin G, Craddock L, Topaloglu U, Kucera G, O'Neill S, Levine EA, Sun P, Watabe K, Lu Y, Alexander-Miller MA, Pasche B, Miller LD, Zhang W. Song Q, et al. Cancer Med. 2019 Jun;8(6):3072-3085. doi: 10.1002/cam4.2113. Epub 2019 Apr 29. Cancer Med. 2019. PMID: 31033233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page